Published in
American Chemical Society, Journal of Medicinal Chemistry, 18(64), p. 13873-13892, 2021
DOI: 10.1021/acs.jmedchem.1c01273
Links
Tools
A novel mitragynine analog with low efficacy mu-opioid receptor agonism displays antinociception with attenuated adverse effects
Journal article published in 2021 by
Soumen Chakraborty,
Jeffrey F. DiBerto 
,
Abdelfattah Faouzi,
Sarah M. Bernhard,
Anna M. Gutridge,
Steven Ramsey,
Yuchen Zhou,
Davide Provasi,
Nitin Nuthikattu,
Rahul Jilakara,
Melissa N. F. Nelson,
Wesley B. Asher,
Shainnel O. Eans,
Lisa L. Wilson,
Satyanarayana M. Chintala
and other authors.
,
Abdelfattah Faouzi,
Sarah M. Bernhard,
Anna M. Gutridge,
Steven Ramsey,
Yuchen Zhou,
Davide Provasi,
Nitin Nuthikattu,
Rahul Jilakara,
Melissa N. F. Nelson,
Wesley B. Asher,
Shainnel O. Eans,
Lisa L. Wilson,
Satyanarayana M. Chintala
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 